NM
Insider
Neil F. McFarlane
President and CEONeil F. McFarlane (President and CEO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Zevra Therapeutics, Inc. (ZVRA). The largest single filing was $854K of ZVRA (91,000 sh × $9.38, as filed), executed Feb 2.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.2M
shares × price, as filed
Last traded
Feb 9
Filed Feb 10
Median ADV $19.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
ZVRARecent filings
ZVRASALE
Zevra Therapeutics, Inc.
View filing →
$125K14,625 sh × $8.56
Exec Feb 9
Filed Feb 10 · 5:30 PM ET ZVRASALE Zevra Therapeutics, Inc. View filing → $854K
91,000 sh × $9.38
Exec Feb 2
Filed Feb 2 · 5:30 PM ET ZVRASALE Zevra Therapeutics, Inc. View filing → $211K
19,500 sh × $10.82
Exec Oct 10 2025
Filed Oct 10 2025 · 5:30 PM ET ZVRASALE Zevra Therapeutics, Inc. View filing → $727K
91,817 sh across 2 lots
Exec Feb 13 2025
Filed Feb 14 2025 · 5:30 PM ET